| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3930351 | European Urology Supplements | 2011 | 4 Pages |
Abstract
The second TUR confirmed the presence of residual cancer and tumour understaging in a significant number of T1 and high-grade tumours. This is a strong argument that supports the recommendation of second TUR in patients with T1 or high-grade NMIBC.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Marko Babjuk,